Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exagen Inc (NQ: XGN )

2.700 -0.270 (-9.09%)
Streaming Delayed Price Updated: 2:52 PM EST, Nov 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exagen Inc

< Previous 1 2 3 4 5 Next >
Exagen Inc. Reports Third Quarter 2024 Results
From Exagen Inc.
Via GlobeNewswire
Earnings Scheduled For November 12, 2024
Via Benzinga
Exagen to Announce Third Quarter 2024 Results on November 12, 2024
From Exagen Inc.
Via GlobeNewswire
Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence
From Exagen Inc.
Via GlobeNewswire
Earnings Outlook For Exagen
Via Benzinga
Exagen Inc. (NASDAQ: XGN) Near the Top of Equities by Percentage Gain on 1/29
Via Investor Brand Network
Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference
From Exagen Inc.
Via GlobeNewswire
Market Mayhem Winners: What Stocks Are Up Today?
What stocks are up today? It’s a natural question following the implosion of the global markets and the answer might surprise you. 
Via InvestorPlace
XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q2 2024
XGN stock results show that Exagen beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record Performance
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference
From Exagen Inc.
Via GlobeNewswire
Exagen Appoints Jeffrey G. Black as New Chief Financial Officer
From Exagen Inc.
Via GlobeNewswire
Exagen to Announce Second Quarter 2024 Results on August 5, 2024
From Exagen Inc.
Via GlobeNewswire
XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q1 2024
XGN stock results show that Exagen beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
From Exagen Inc.
Via GlobeNewswire
Exagen Announces Campaign for Lupus Awareness Month
From Exagen Inc.
Via GlobeNewswire
Exagen to Announce First Quarter 2024 Results on May 13, 2024
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. Announces Changes to the Board of Directors
From Exagen Inc.
Via GlobeNewswire
XGN Stock Earnings: Exagen Beats EPS, Beats Revenue for Q4 2023
XGN stock results show that Exagen beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
From Exagen Inc.
Via GlobeNewswire
Earnings Scheduled For March 18, 2024
Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to report earnings for its fourth quarter. 
Via Benzinga
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
From Exagen Inc.
Via GlobeNewswire
Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
From Exagen Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.